论文部分内容阅读
目的:分析在肝功能衰竭患者预后评估中进行血清总胆固醇检测的价值。方法:选择2014年12月至2016年11月在梅州市人民医院接受治疗的肝功能衰竭患者84例,根据患者具体疾病类型分成2组,测定血清总胆固醇水平,比较其结果。结果:慢性组总胆固醇水平为(2.13±0.30)mmol·L~(-1),慢加急性组为(2.36±0.40)mmol·L~(-1);治愈患者总胆固醇水平为(2.54±0.31)mmol·L~(-1),死亡患者为(1.86±0.32)mmol·L~(-1);血清总胆固醇值≥2 mmol·L~(-1)的患者治愈率为79.24%,死亡率为20.76%,血清总胆固醇值<2 mmol·L~(-1)的治愈率和死亡率分别为45.16%、54.84%。结论:检测肝功能衰竭患者血清总胆固醇水平能够准确评估患者预后。
Objective: To analyze the value of serum total cholesterol in the prognosis evaluation of patients with liver failure. Methods: Eighty-four patients with liver failure who were treated in Meizhou People’s Hospital from December 2014 to November 2016 were selected and divided into two groups according to their specific disease types. The serum total cholesterol level was measured and the results were compared. Results: The total cholesterol level in the chronic group was (2.13 ± 0.30) mmol·L -1, (2.36 ± 0.40) mmol·L -1 in the slow and acute group, and the total cholesterol level in the cured group was (2.54 ± 0.31) mmol·L -1, and the death rate was (1.86 ± 0.32) mmol·L -1. The cure rate was 79.24% in serum total cholesterol≥2 mmol·L -1, The mortality rate was 20.76%. The cure rate and mortality of serum total cholesterol <2 mmol·L -1 were 45.16% and 54.84% respectively. Conclusion: Detecting serum total cholesterol levels in patients with liver failure can accurately assess the prognosis of patients.